Dr. Nicole Paulk: 80% of protein-coding genes fit inside AAV viral vectors
Dr. Nicole Paulk · All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk · Sep 25, 2023 · at 28:41
Dr. Nicole Paulk clarifies that despite AAV vector capacity limits, 80% of human protein-coding genes can fit for gene transfer therapies.
0:00 / 0:03exact quote · 3.9s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Of all protein coding genes, 80% of those genes can fit within my virus.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Dr. Nicole Paulk
Dr. Nicole Paulk: Viral gene therapy can completely cure inherited genetic blindness
“So we're able to completely cure blindness.”
Prediction: Every person alive today will eventually receive viral gene therapy
“I promise you, in your lifetime, no matter how old any of you are in this audience, in your lifetime you are going to receive a viral gene therapy as medicine.”
Anti-aging rejuvenation gene therapies are likely five to ten years away
“We're probably five to 10 years out on being ready to do this, but this is absolutely coming in your lifetime. You could get a rejuvenation gene therapy.”
FDA blocks clinical trials for lifestyle gene therapies like aging or sleep
“The FDA only lets you queue up clinical trials to test drugs that are for diseases, but aging is not a disease state. Wanting to sleep fewer hours is not a disease state. Insomnia is, but wanting to just sleep fewer hours and be fully rested is not a disease s…”
Catalent Pharma has a 2.5-year waitlist for 5,000-liter viral bioreactors
“But viruses are still something, like, if I queue up the biggest CDMO in the world, Catalent Pharma and ask them to make us a 5000 liter bioreactor virus, they'll absolutely say yes, but they won't even touch it for two and a half years.”